Results 141 to 150 of about 74,509 (297)

Advancing Precision Medicine through clinical grade whole genome sequencing, return of results and deep brain stimulation [PDF]

, 2013
CSHL Meetings and Course: Precision Medicine: Personal Genomes & Pharmacogenomics, November 13th - November 16th ...
Lyon, Gholson J.
core  

Genomics and epilepsy: Opportunities to improve understanding and management

Developmental Medicine &Child Neurology, EarlyView.
Accessing the entire genome, beyond any single causal variant for an individual's condition, may reveal additional genetic information of value in the understanding or care for that person. Combining such data with additional sources of information from that individual may enhance understanding and care further.
Sanjay M. Sisodiya
wiley   +1 more source

Assessment of knowledge, perceptions, and readiness of healthcare professionals towards clinical pharmacogenomics implementation in Qatar: a mixed-method study

Journal of Pharmaceutical Policy and Practice
Introduction Pharmacogenomics implementation in clinical practice is anticipated to improve our understanding of individual variations in drug response and optimise the safety and efficacy of drug therapy.
Shaikha Jabor Alnaimi, Fatima Ajaj, Ahmed Awaisu, Turfa Alhathal, Shaban Mohammed, Moza Alhail   +5 more
doaj   +1 more source

Pharmacogenomics and schizophrenia: clinical implications [PDF]

, 2001
Anil K. Malhotra
openalex   +1 more source

Genetic variation affecting exon skipping contributes to brain structural atrophy in Alzheimer's disease [PDF]

, 2018
Genetic variation in cis-regulatory elements related to splicing machinery and splicing regulatory elements (SREs) results in exon skipping and undesired protein products.
Alzheimer’s Disease Neuroimaging Initiative, Han, Seonggyun, Horgousluoglu, Emrin, Kim, Dokyoon, Kim, Dongwook, Lee, Younghee, Nho, Kwangsik, Risacher, Shannon L., Saykin, Andrew J.   +8 more
core  

Personalized care of paediatric drug‐resistant epilepsy in Africa: A single‐centre pilot study utilizing mobile health and genetic testing

Developmental Medicine &Child Neurology, EarlyView.
Abstract Aim To evaluate personalized care or precision medicine initiatives, including mobile health (mHealth) technology and genetic screening, in a South African paediatric epilepsy clinic. Method This exploratory prospective observational pilot study included 39 children aged 4 years or older with drug‐resistant epilepsy (ongoing seizures despite ...
Ian S. Olivier, Karen Fieggen, Sandra Komarzynski, Elin H. Davies, Irene Muchada, Caitlin McIntosh, Alina Esterhuizen, Richard J. Burman, Jo M. Wilmshurst, And the University of Cape Town (UCT) Human Genetics Precision Medicine Epilepsy Group, Nicholas Loxton, Shrinav R Dawlatt, Akshay Vanmali   +12 more
wiley   +1 more source

Pharmacogenomics and Big Data in medical oncology: developments and challenges

Therapeutic Advances in Medical Oncology
Medical oncology, through conventional chemotherapy as well as targeted drugs, remains an important component of cancer patient management, particularly for systemic disease.
Loredana G. Marcu, David C. Marcu
doaj   +1 more source

Pharmacogenomics of hypoxia and oxidative stress in blood vessels

, 1999
Toshio Tanaka, Homare Amano, Yuhei Nishimura, Masaaki Hayashi, Michiko Naka, Hiroshi Tsunoda   +5 more
openalex   +1 more source

Searching for Pharmacogenomic Markers: The Synergy between Omic and Hypothesis-Driven Research [PDF]

, 2001
John N. Weinstein
openalex   +1 more source

Colonial Legacies, Postcolonial Biologies: Gender and the Promises of Biotechnology [PDF]

, 2015
Three decades of work in the feminist studies of science and technology have shaped our evolving understandings of the relationships between sex, gender, and biotechnology.
Subramaniam, Banu
core   +1 more source